Cargando…
Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest
BACKGROUND: Targeted therapies have been proven as promising in the treatment of breast cancer and have improved survival and quality of life in advanced breast cancer. We previously identified a novel peptide SA12 which showed significant activity in the inhibition of proliferation and induction of...
Autores principales: | Yang, Longfei, Liu, Huanran, Long, Min, Wang, Xi, Lin, Fang, Gao, Zhaowei, Zhang, Huizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935185/ https://www.ncbi.nlm.nih.gov/pubmed/29750041 http://dx.doi.org/10.2147/OTT.S154337 |
Ejemplares similares
-
Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
por: Núñez, Mariel, et al.
Publicado: (2013) -
Impaired G2/M cell cycle arrest induces apoptosis in pyruvate carboxylase knockdown MDA-MB-231 cells
por: Rattanapornsompong, Khanti, et al.
Publicado: (2021) -
Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to Centchroman
por: Singh, Neetu, et al.
Publicado: (2012) -
Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis
por: Razak, Nursyamirah Abd, et al.
Publicado: (2019) -
Dillenia Suffruticosa Extract Inhibits Proliferation of Human Breast Cancer Cell Lines (MCF-7 and MDA-MB-231) via Induction of G(2)/M Arrest and Apoptosis
por: Armania, Nurdin, et al.
Publicado: (2013)